SynthesisPharmacoEconomics2023

Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Giovany Orozco Leal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.